Agenus Inc.
AGEN
$3.81
$0.051.33%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
3/20/2026
-
Tickeron - Technical Analysis
3/19/2026
-
Tickeron - Technical Analysis
3/19/2026
-
Tickeron - Technical Analysis
3/18/2026
-
MarketBeat
3/18/2026
-
Tickeron - Technical Analysis
3/18/2026
-
Tickeron - Technical Analysis
3/18/2026
-
Tickeron - Technical Analysis
3/18/2026
-
Tickeron - Technical Analysis
3/17/2026
-
Simply Wall St
3/17/2026
-
Business Wire
3/17/2026
-
MarketBeat
3/17/2026
-
Tickeron - Technical Analysis
3/17/2026
-
Nasdaq News: Stocks
3/17/2026
-
Zacks Investment Research
3/16/2026
-
TipRanks Financial Blog
3/16/2026
-
Business Wire
3/14/2026
-
Tickeron - Stocks
3/13/2026
-
Zacks Investment Research
3/12/2026
-
Tickeron - Technical Analysis
3/11/2026
-
Tickeron - Stocks
3/11/2026
-
Tickeron - Stocks
3/10/2026
-
Seeking Alpha - Healthcare
3/10/2026
-
SeekingAlpha.com: All News
3/10/2026
-
TipRanks Financial Blog
3/10/2026
-
The Fly
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, March 16, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 11 and 15 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
781 674 4400
Address
3 Forbes Road
Lexington, MA 02421-7305
Lexington, MA 02421-7305
Country
Year Founded
Business Description
Sector
Agenus Inc., a clinical-stage biotechnology company, discovers and develops immunotherapies for cancer and infectious diseases in the United States and internationally. It offers Retrocyte...
more